Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA213283
Max Phase: Preclinical
Molecular Formula: C22H24ClN3S
Molecular Weight: 361.51
Molecule Type: Small molecule
Associated Items:
ID: ALA213283
Max Phase: Preclinical
Molecular Formula: C22H24ClN3S
Molecular Weight: 361.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC/N=c1/cc2sc3cc(N(CC)CC)ccc3nc-2c2ccccc12.Cl
Standard InChI: InChI=1S/C22H23N3S.ClH/c1-4-23-19-14-21-22(17-10-8-7-9-16(17)19)24-18-12-11-15(13-20(18)26-21)25(5-2)6-3;/h7-14H,4-6H2,1-3H3;1H/b23-19-;
Standard InChI Key: QYNCZLPRFXWLEN-PDEWKSAASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 361.51 | Molecular Weight (Monoisotopic): 361.1613 | AlogP: 5.32 | #Rotatable Bonds: 4 |
Polar Surface Area: 28.49 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 7.30 | CX LogP: 4.90 | CX LogD: 4.65 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.36 | Np Likeness Score: -1.26 |
1. Foley JW, Song X, Demidova TN, Jalil F, Hamblin MR.. (2006) Synthesis and properties of benzo[a]phenoxazinium chalcogen analogues as novel broad-spectrum antimicrobial photosensitizers., 49 (17): [PMID:16913718] [10.1021/jm060153i] |
2. Vecchio D, Bhayana B, Huang L, Carrasco E, Evans CL, Hamblin MR.. (2014) Structure-function relationships of Nile blue (EtNBS) derivatives as antimicrobial photosensitizers., 75 [PMID:24561676] [10.1016/j.ejmech.2014.01.064] |
3. Wang Y,Pan Z,Cheng XL,Zhang K,Zhang X,Qin Y,Fan J,Yan T,Han T,Shiu KK,Hau SC,Mak NK,Kwong DWJ,Liu X,Li M,Deng G,Zheng Q,Lu J,Li D. (2021) A red-light-activated sulfonamide porphycene for highly efficient photodynamic therapy against hypoxic tumor., 209 [PMID:33010634] [10.1016/j.ejmech.2020.112867] |
Source(1):